[Antimalarial agents in rheumatic diseases. New therapeutic aspects of an old medication].
Barthel
H R
HR
Department of Medicine, UCLA School of Medicine, Cedars-Sinai Medical Center, USA.
Meier
L G
LG
Wallace
D J
DJ
D000962:Antimalarials / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001327:Autoimmune Diseases / Q000188:drug therapy; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D012216:Rheumatic Diseases / Q000188:drug therapy*
D000962:Antimalarials; D005343:Fibrinolytic Agents; D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents